Apheresis treatment of cryoglobulinemic vasculitis: A multicentre cohort study of 159 patients
- 1 October 2018
- journal article
- research article
- Published by Elsevier in Transfusion and Apheresis Science
- Vol. 57 (5) , 639-645
Abstract
No abstract availableKeywords
Funding Information
- Klinisk Institut, Aalborg Universitet
This publication has 38 references indexed in Scilit:
- Life-Threatening Cryoglobulinemic Patients With Hepatitis CMedicine, 2013
- Impact of Cryoglobulinemic Syndrome on the Outcome of Chronic Hepatitis C Virus InfectionMedicine, 2013
- Vasculitic emergencies in the intensive care unit: a special focus on cryoglobulinemic vasculitisAnnals of Intensive Care, 2012
- A randomized controlled trial of rituximab following failure of antiviral therapy for hepatitis C virus–associated cryoglobulinemic vasculitisArthritis & Rheumatism, 2011
- Preliminary classification criteria for the cryoglobulinaemic vasculitisAnnals of the Rheumatic Diseases, 2011
- Clinical Spectrum, Treatment, and Outcome of Patients with Type II Mixed Cryoglobulinemia without Evidence of Hepatitis C InfectionThe Journal of Rheumatology, 2011
- Immunoadsorption apheresis and immunosuppressive drug therapy in the treatment of complicated HCV‐related cryoglobulinemiaJournal of Clinical Apheresis, 2009
- Hyperviscosity Syndrome in Cryoglobulinemia: Clinical Aspects and Therapeutic ConsiderationsSeminars in Thrombosis and Hemostasis, 2003
- Haemorheological changes in mixed cryoglobulinaemia during apheresis treatmentTransfusion Science, 1996
- The effect of combination therapy (steroids, immunosuppressives, and plasmapheresis) on 5 mixed cryoglobulinemia patients with renal, neurologic, and vascular involvementArthritis & Rheumatism, 1981